Skip to main content

Geriatrics and Gerontology

Editor's Choice

Cognitive impairment and affective disorders in Parkinson’s disease

Mild cognitive impairment, dementia, and affective disorders are the most common and debilitating non-motor symptoms in PD. Here are the DGN's recommendations on diagnosis and treatment.

Intravitreal injection of anti-VEGF resulting in heart failure

An unusual case of heart failure caused by ten years of anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. The HF resolved after cessation of anti-VEGF injections. 

Time in HbA1c range linked to dementia risk for older men with diabetes

Maintaining glycated hemoglobin levels within target range may reduce the risk for developing Alzheimer’s disease and related dementias in older men with diabetes.

Ageing well with diabetes: the role of technology

The use of diabetes therapeutic technology is being advocated for older people, but what are the benefits and challenges of implementing technology solutions in older individuals with diabetes?

Low-dose edoxaban for patients over 80 years with AF

Halving the dose of edoxaban (from 60mg to 30mg) significantly reduces major bleeding events without increasing ischemic events in people with atrial fibrillation aged 80 years or older.

Impulse control disorders, psychosis, and delirium in PD

Updated recommendations from DGN on the diagnosis and therapeutic management of impulse control disorders, psychosis, and delirium associated with Parkinson’s disease.

Antidepressant choice key when used alongside CYP2D6-metabolized opioids

Using CYP2D6-inhibiting antidepressants concomitantly with CYP2D6-metabolized opioids is associated with worsening pain and increased adverse events.

Right ventricular benefits with dapagliflozin in people with HFpEF

Dapagliflozin significantly improves pulmonary vascular load and right ventricular function during exercise in people with heart failure with preserved ejection fraction.

Testosterone therapy for functional hypogonadism

What is the evidence for testosterone therapy in men with functional hypogonadism? Can it address weak guideline recommendations and historic concerns about long-term safety?

Diabetic neuropathy: a guide to pain management

Diabetic neuropathy is a frequent complication of diabetes. With no treatments targeting the underlying mechanisms, strategies focus on preventative care and pain management.

Less risk of hemorrhagic events with apixaban in cirrhosis patients with AF

Apixaban is associated with lower rates of major hemorrhagic events than rivaroxaban or warfarin in patients with cirrhosis and nonvalvular atrial fibrillation.

GLP-1 RAs not linked to suicidality in older people with type 2 diabetes

GLP-1 receptor agonists are not linked to an increased risk for suicidal thoughts or actions versus SGLT-2 or DPP4 inhibitors in older adults with type 2 diabetes.

Myasthenia gravis mimicking acute lacunar stroke

Diagnosing myasthenic crisis with atypical presentation is very challenging, especially in elderly patients who can present with isolated dysarthria, suggesting lacunar stroke.

Osteosarcopenia and mortality in patients undergoing TAVR

Older adults undergoing transcatheter aortic valve replacement who have osteosarcopenia are at increased risk for mortality and worsening disability.

Challenges in left bundle branch area pacing

Left bundle branch area pacing, which captures the left conduction system and progresses along the Purkinje system, is a novel pacing technique that shows promise. However these two cases describe procedural complications to be wary of. 

Aging diseases in transgender people

How do aging-related diseases impact older transgender individuals? Beyond the inherent risk of chronic disease, there is a cognitive and psychiatric risk, and a reluctance to adhere to screening programs.

Tau PET: best biomarker for dementia?

Tau PET is better than amyloid-β PET and MRI for predicting progression from mild cognitive impairment to dementia.

Parkinson’s disease guidelines

Latest advice from DGN, in collaboration with ÖGN and SNG, on diagnostics, pharmacotherapy, and invasive treatment options to manage motor and non-motor symptoms.

Managing the foot and ankle in rheumatoid arthritis

A clinical practice guideline on the management of foot and ankle pathologies caused by rheumatoid arthritis, covering orthoses, therapeutic footwear, surgery, and self-care strategies and education.

Statin therapy reduces CVD risk and mortality in the over 75s

Statin therapy in individuals aged 75 years and older reduces the risk for CV diseases and all-cause mortality, with benefits persisting in those aged 85 years and older.